Publications

Chapters and Manuals

• Pink Book’s Chapter on Diphtheria
  Epidemiology & Prevention of Vaccine-Preventable Diseases textbook
• Travelers’ Health: Yellow Book—Chapter on Diphtheria
  CDC’s Health Information for International Travel 2014
• Surveillance Manual’s Chapter on Diphtheria
  Manual from the Surveillance of Vaccine-Preventable Diseases textbook

Articles

Vaccine Licensures and Recommendations

• Havers FP, Moro P, Hunter P, Hariri S, Bernstein H. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccines — Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2020;69(3);77–83.
• Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2018;67(2):1–44.
• Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013;62(07):131—5.
• Updated Recommendation for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Adults 65 Years and Older—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2012;61(25):468—70.
• Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011;60(RR07):1—45.
• Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged Less than 12 Months—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(41):1424—6.
• FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. MMWR Morb Mortal Wkly Rep. 2011;60(37):1279—80.
• General Recommendations on Immunization. MMWR Morb Mortal Wkly Rep. 2011;60(RR02):1—60.
• Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(01):13—15.
• Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and their Infants. MMWR Morb Mortal Wkly Rep. 2008;5(04):1—47.
• Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. MMWR Morb Mortal Wkly Rep. 2006;55(RR17):1—33.
• Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. MMWR Morb Mortal Wkly Rep. 2006;55(RR3):1—34.
• Combination Vaccines for Childhood Immunization. MMWR Morb Mortal Wkly Rep. 1999;48(RR05):1—15.
• Diphtheria, Tetanus, and Pertussis: Recommendations for Vaccine Use. MMWR Morb Mortal Wkly Rep. 1991;40(RR10):1—28.

Surveillance, Epidemiology and Outbreaks

• Griffith J, Bozio CH, Poel AJ, et al. Imported toxin-producing cutaneous diphtheria — Minnesota, Washington, and New Mexico, 2015–2018. MMWR Morb Mortal Wkly Rep. 2019;68:281–284.
• Weil LM, Butler C, Howell KR, et al. Notes from the Field: Conjunctivitis caused by toxigenic Corynebacterium ulcerans — Missouri, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:615–616.
• CDC. Notes from the field: Respiratory diphtheria-like illness caused by toxigenic Corynebacterium ulcerans—Idaho, 2010. MMWR Morb Mortal Wkly Rep. 2011;60 (03):77.
• CDC. Fatal respiratory diphtheria in a U.S. traveler to Haiti—Pennsylvania, 2003. MMWR Morb Mortal Wkly Rep. 2004;52(53):1285—6.
• CDC. Toxigenic Corynebacterium diphtheriae—Northern Plains Indians. MMWR Morb Mortal Wkly Rep. 1997;46(22):506—10.
• Availability of diphtheria antitoxin through an Investigational New Drug protocol. MMWR Morb Mortal Wkly Rep. 2004;53(19):413.
• Bisgard KM, Hardy IRB, Popovic T, et al. Respiratory diphtheria in the United States, 1980 through 1995external icon. Am J Public Health. 1998;88:787—91.
• Dittmann S. Epidemic diphtheria in the Newly Independent States of the former USSR—Situation and lessons learnedexternal icon. Int Assoc Biol Standard. 1997;25:179—86.
• Farizo KM, Strebel PM, Chen RT, et al. Fatal respiratory disease due to Corynebacterium diphtheriae: Case report and review of guidelines for management, investigation, and controlexternal icon. Clin Infect Dis. 1993;16:59—68.

Laboratory

• Marini RP, Cassiday PK, Venezia J, et al. Corynebacterium ulcerans in ferretsexternal icon. Emerg Infect Dis. 2014;20:159—61.
• Venezia K, Cassiday PK, Marini RP, et al. Characterization of Corynebacterium species in macaquesexternal icon. J Med Microbiol. 2012;61:1401—8.
• Bolt F, Cassiday P, Tondella ML, et al. Multilocus sequence typing identifies evidence for recombination and two distinct lineages of Corynebacterium diphtheriaeexternal icon. J Clin Microbiol. 2010;48:4177—85.
• Hall AJ, Cassiday PK, Bernard KA, et al. Isolation of novel Corynebacterium diphtheriae from domestic cats. Emerg Infect Dis. 2010;16:688—91.
• Cassiday PK, Pawloski LC, Tiwari T, et al. Analysis of toxigenic Corynebacterium ulcerans strains revealing potential for false-negative real-time PCR resultsexternal icon. J Clin Microbiol. 2009; 46:331—3.
• Mothershed EA, Cassiday PK, Pierson K, et al. Development of a real-time fluorescent PCR assay for rapid detection of the diphtheria toxin geneexternal icon. J Clin Microbiol. 2002;40:4713—19.
• Popovic T, Kim C, Reiss JA, et al. Use of molecular subtyping to document long-term persistence of Corynebacterium diphtheriae in South Dakotaexternal icon. J Clin Microbiol. 1999;37:1092—9.